Sen. JD Vance asked the Justice Department to investigate dozens of hospitals for allegedly using misleading or fraudulent billing codes to obtain insurance payments for gender‑affirming care, citing an HHS report titled "Wolves in White Coats." The report accuses some hospitals and advocacy groups of exploiting billing practices and describes transgender youth as "captive patients." Major medical organizations and LGBTQ+ groups have rejected the report's findings, defending established clinical guidance and warning that political interference could harm patients. The request follows an executive order blocking Medicaid and CHIP funds for gender‑affirming treatments.
JD Vance Asks DOJ To Probe Hospitals Over Alleged Fraud In Billing For Gender‑Affirming Care

Republican Senator JD Vance on Thursday asked the U.S. Justice Department to investigate claims that dozens of hospitals and pediatric gender clinics improperly billed insurers for gender‑affirming treatments provided to transgender patients. In a letter to Acting Attorney General Todd Blanche, Vance cited findings from a Department of Health and Human Services (HHS) report released the same day and urged scrutiny of alleged misleading or fraudulent diagnostic and billing codes, according to POLITICO.
What Vance requested
Vance, who leads the White House Anti‑Fraud Task Force, forwarded the HHS report — titled "Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of 'Gender Medicine'" — and asked DOJ to evaluate potential improper Medicaid and insurance claims by multiple institutions. "Some pediatric gender clinics and children's hospitals have apparently used misleading or even fraudulent diagnostic and billing codes to ensure that insurance companies will cover the procedures," he wrote.
Claims in the HHS report
The HHS document accuses some hospitals of using billing practices that allowed them to obtain insurance coverage and create revenue streams tied to what the report calls "sex‑rejecting procedures." It also characterizes many transgender youth who sought care as "captive patients" and alleges that some advocacy groups — including the World Professional Association for Transgender Health (WPATH) — encouraged vague or improper billing to secure coverage.
"When a child is in distress, many parents will go to any length to find help and to relieve the pain... Instead, parents encountered wolves in white lab coats who pushed vulnerable children down a path towards irreversible harm from sex‑rejecting procedures," the report states.
Medical community and advocacy responses
Major medical organizations continue to support gender‑affirming care for adults and for minors under appropriate clinical supervision. The American Medical Association and the American Academy of Pediatrics (AAP) maintain clinical guidance endorsing care when provided by qualified clinicians.
WPATH disputed HHS's characterization, saying clinical practice guidelines such as Standards of Care Version 8 are based on evidence, clinical expertise, patient values and context. In prior statements, WPATH has accused HHS of misrepresenting its research and recommendations and emphasized the need for ongoing outcome research and developmentally appropriate services.
The Human Rights Campaign (HRC) criticized the HHS report as biased, asserting the agency relied on a hand‑picked panel and research from anti‑trans groups. HRC President Kelley Robinson said the report and actions stemming from it inflict real harm on families and transgender youth.
The AAP also condemned Vance's request as political interference in medical practice. "Allowing the government to determine which patient groups deserve care sets a dangerous precedent, and children and families will bear the consequences," AAP President Susan J. Kressly said.
Policy context
The request for investigation comes amid a broader federal effort to limit access to gender‑affirming care. Earlier that week, President Donald Trump issued an executive order barring Medicaid and Children's Health Insurance Program (CHIP) funds from being used for gender‑affirming treatments; the HHS report's cited billing activity would have preceded that order.
Where this leaves the issue
The dispute highlights a deepening clash between a federal agency and conservative lawmakers on one side and medical associations and LGBTQ+ advocates on the other. DOJ's response to Vance's letter — whether it opens a formal inquiry and what findings emerge — will shape legal and policy debates over billing practices and access to gender‑affirming care.
Help us improve.
























